Longevity.Technology (@LongevityTech)· LongevityTech·· 3 小时前评分10
Lancet Neurology研究：lecanemab血蛋白反应差异
A Lancet Neurology study of 130 blood proteins in patients receiving lecanemab suggests amyloid clearance and cognitive response differ.
导读
一项发表于Lancet Neurology的研究，对接受lecanemab治疗的患者进行了130种血液蛋白分析，提示淀粉样蛋白清除与认知反应存在差异。 https://vist.ly/5nn29 #longevity #geroscience #lecanemab #amyloid #bloodproteins
来源：Longevity.Technology (@LongevityTech) · x.com